NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
3.450
-0.150 (-4.17%)
Nov 9, 2026, 11:06 AM EST - Market open
NEXGEL Revenue
NEXGEL had revenue of $3.69M in the quarter ending June 30, 2026, with 27.81% growth. This brings the company's total for the last twelve months to $12.07M, up 3.38% year-over-year. In the year 2025, NEXGEL had annual revenue of $11.42M with 31.46% growth. That makes NEXGEL the 36,540th largest company in the world by revenue and 4,791st in the United States.
Revenue (ttm)
$12.07M
Revenue Growth
+3.38%
P/S Ratio
0.15
Revenue / Employee
$635,105
Employees
19
Market Cap
1.68M
Revenue by Segment
- Nexgel 8.61M 75.4%
- CGN JV 2.81M 24.6%
Fiscal year ended Dec 31, 2025 See the full NEXGEL breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.42M | 2.73M | 31.46% |
| Dec 31, 2024 | 8.69M | 4.60M | 112.47% |
| Dec 31, 2023 | 4.09M | 2.04M | 99.66% |
| Dec 31, 2022 | 2.05M | 497.00K | 32.04% |
| Dec 31, 2021 | 1.55M | 877.00K | 130.12% |
| Dec 31, 2020 | 674.00K | -43.00K | -6.00% |
| Dec 31, 2019 | 717.00K | -1.50M | -67.60% |
| Dec 31, 2018 | 2.21M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Bionano Genomics | 30.18M |
| Nephros | 21.58M |
| Milestone Scientific | 9.42M |
| Lucyd | 3.41M |
| Femasys | 2.30M |
| Cuprina Holdings (Cayman) Limited | 38.79K |
NXGL News
- 13 days ago - NexGel regains compliance with Nasdaq - TheFly
- 13 days ago - NEXGEL Regains Compliance with Nasdaq Listing Requirement - GlobeNewsWire
- 4 weeks ago - Nexgel Inc trading halted, news pending - TheFly
- 6 weeks ago - NEXGEL Transcript: Investor update - Transcripts
- 6 weeks ago - NEXGEL Slides: Investor update - Filings
- 6 weeks ago - NEXGEL Announces Dial-In Details for Investor Update Call - GlobeNewsWire
- 7 weeks ago - NEXGEL Announces Date for Investor Update Call - GlobeNewsWire
- 2 months ago - NexGel downgraded to Hold from Buy at Maxim - TheFly